Allogenic umbilical cord-derived mesenchymal stem cell (University of Jordan)

N/A

Report date: 2025/02/20 20:00:06

Base Information

Drug NameAllogenic umbilical cord-derived mesenchymal stem cell (University of Jordan)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJordan

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe University Of Jordan

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe University Of Jordan

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A